Stacy A. Coen
Net Worth

Last updated:

What is Stacy A. Coen net worth?

The estimated net worth of Ms. Stacy A. Coen is at least $5,214,702 as of 5 Feb 2024. She has earned $4,436,762 from insider trading and has received compensation worth at least $777,940 in ImmunoGen, Inc..

What is the salary of Stacy A. Coen?

Ms. Stacy A. Coen salary is $388,970 per year as Senior Vice President & Chief Bus. Officer in ImmunoGen, Inc..

How old is Stacy A. Coen?

Ms. Stacy A. Coen is 54 years old, born in 1971.

What stocks does Stacy A. Coen currently own?

As insider, Ms. Stacy A. Coen owns shares in one company:

Company Title Shares Price per share Total value
ImmunoGen, Inc. (IMGN) Senior Vice President & Chief Bus. Officer 73,274 $0 $0

What does ImmunoGen, Inc. do?

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.

IMGN logo
IMGN
ImmunoGen, Inc.

Stacy A. Coen insider trading

ImmunoGen, Inc.

Ms. Stacy A. Coen has made 7 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently she sold 4,583 units of IMGN stock worth $134,282 on 5 Feb 2024.

The largest trade she's ever made was exercising 100,210 units of IMGN stock on 9 Aug 2023. As of 5 Feb 2024 she still owns at least 73,274 units of IMGN stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 4,583 $29.3 $134,282
Option
Common Stock 14,350 N/A N/A
Option
Restricted Stock Unit 14,350 N/A N/A
Option
Common Stock 30,000 $5.32 $159,600
Option
Stock Option (Right to Buy) 30,000 $5.32 $159,600
Sale
Common Stock 3,826 $29.2 $111,719
Option
Stock Option (Right to Buy) 2,200 $4.92 $10,824
Option
Common Stock 2,200 $4.92 $10,824
Option
Common Stock 76,023 $7.69 $584,617
Sale
Common Stock 78,223 $16.05 $1,255,479
Option
Stock Option (Right to Buy) 76,023 $7.69 $584,617
Sale
Common Stock 4,100 $16.01 $65,641
Option
Common Stock 3,200 $4.92 $15,744
Option
Common Stock 900 $7.69 $6,921
Option
Stock Option (Right to Buy) 3,200 $4.92 $15,744
Option
Stock Option (Right to Buy) 900 $7.69 $6,921
Option
Common Stock 20,986 $4.92 $103,251
Option
Stock Option (Right to Buy) 20,986 $4.92 $103,251
Option
Stock Option (Right to Buy) 5,300 $7.69 $40,757
Option
Common Stock 5,300 $7.69 $40,757
Option
Common Stock 26,006 $7.69 $199,986
Option
Stock Option (Right to Buy) 26,006 $7.69 $199,986
Option
Common Stock 100,210 $4.92 $493,033
Option
Stock Option (Right to Buy) 100,210 $4.92 $493,033
Sale
Common Stock 100,210 $14.2 $1,422,982
Option
Common Stock 80,326 $4.92 $395,204
Option
Stock Option (Right to Buy) 80,326 $4.92 $395,204
Sale
Common Stock 80,326 $17.05 $1,369,558
Sale
Common Stock 4,255 $18.12 $77,101
Option
Stock Option (Right to Buy) 4,255 $4.92 $20,935
Option
Common Stock 4,255 $4.92 $20,935

ImmunoGen key executives

ImmunoGen, Inc. executives and other stock owners filed with the SEC: